Pliant Therapeutics
Price & Volume
Stats
See more52W Range | $1.10-$15.80 |
Market Cap | $97M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.86 |
News
See moreYahoo Finance • 11 days ago
Idiopathic Pulmonary Fibrosis Research Report 2025-2035: Market Led by Roche, Pliant Therapeutics, Bristol-Myers Squibb, and Vicore as Next-Gen Antifibrotics and Targeted Therapies Drive Innovation
Yahoo Finance • 23 days ago
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
Yahoo Finance • 2 months ago
Align downgraded, NetEase upgraded: Wall Street's top analyst calls
Yahoo Finance • 4 months ago
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
About
CEO | Dr. Bernard Coulie M.B.A., M.D., Ph.D. |
Address | 331 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 171 |
